Biocon Biologics likely to receive funds of $100 million from ADQ

Advertisement

Biocon Biologics led by Karan Mazumdar, is in talks with the Abu Dhabi based ADQ to invest upto $100 million in the company. This negotiation came forward after Biocon Biology smashed a deal with Wall Street’s dominant player Goldman Sachs which infused fresh funds of $150 million. ADQ is a state owned enterprise by the UAE government.  

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More